Royce & Associates LP Stevanato Group S.P.A. Transaction History
Royce & Associates LP
- $9.25 Billion
- Q2 2025
A detailed history of Royce & Associates LP transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Royce & Associates LP holds 250,535 shares of STVN stock, worth $5.47 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
250,535
Previous 413,935
39.47%
Holding current value
$5.47 Million
Previous $8.45 Million
27.59%
% of portfolio
0.07%
Previous 0.1%
Shares
15 transactions
Others Institutions Holding STVN
# of Institutions
137Shares Held
50.9MCall Options Held
0Put Options Held
0-
Conestoga Capital Advisors, LLC8.12MShares$177 Million2.96% of portfolio
-
Neuberger Berman Group LLC New York, NY4.47MShares$97.5 Million0.09% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.74MShares$81.5 Million0.06% of portfolio
-
Times Square Capital Management, LLC3.33MShares$72.6 Million1.25% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.28MShares$49.7 Million0.08% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.78B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...